Stem Cells: Opportunities, Hurdles, and Promises from thescientistllc on Vimeo.

Since Sir. Martin Evans’ 1981 identification of embryonic stem cells in mice, stem cells have been at the center of the drive to revolutionize medicine and the drug discovery process. In 1998, human embryonic stem cells were grown in a lab, and the field was further boosted in 2006 with the pivotal discovery of induced pluripotent stem (iPS) cell techniques, which removed the need to destroy embryos. But stem cell research has not come without hurdles and controversy. How far has research come since the first groundbreaking reports were published? For further insight into ongoing challenges in the stem cell arena, the mechanisms and roadblocks encountered in iPS cell technology, and the grand opportunity stem cells represent, The Scientist is bringing together a panel of experts who will share their research, explore cellular reprogramming, and discuss the next steps....

Topics to be covered:

  • Molecular mechanism of induced pluripotency
  • Roadblocks to iPSC reprogramming, and erasing transcriptional memory in cellular reprogramming

Meet the Speaker:

Matthias Stadtfeld, PhD
Assistant Professor
Skirball Institute of Biomolecular Medicine
New York University School of Medicine

Kejin Hu, PhD, MPH
Assistant Professor
UAB Stem Cell Institute
Department of Biochemistry and Molecular Genetics
University of Alabama at Birmingham

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?